机译:卡维地洛治疗的慢性心力衰竭患者中β-肾上腺素能受体多态性与死亡率的关系
Laboratory of Clinical Pharmacology Q7642 Rigshospitalet Copenhagen University Hospital Blegdamsvej 9 DK-2100 Copenhagen;
Department of Clinical Pharmacology Bispebjerg Hospital Bispebjerg Bakke 23 DK-2100 Copenhagen;
Department of Haematology Aalborg Hospital Aarhus University Hospital Sdr. Skovvej 15 DK-9000 Aalborg;
Institute of Human Genetics The Bartholin Building Aarhus University DK-8000 Aarhus C;
Department of Clinical Biochemistry Gentofte Hospital Niels Andersens Vej 65 DK-2900 Hellerup;
The Heart Centre Rigshospitalet Copenhagen University Hospital Blegdamsvej 9 DK-2100 Copenhagen;
Department of Cardiology Gentofte Hospital Niels Andersens Vej 65 DK-2900 Hellerup;
Faculty of Health Science University of Copenhagen Blegdamsvej 3 DK-2200 Copenhagen N Denmark;
carvedilol; drug–gene specific interaction; functional genotype group; heart failure; metoprolol; mortality;
机译:卡维地洛治疗的慢性心力衰竭患者中β-肾上腺素能受体多态性与死亡率的关联。
机译:卡维地洛治疗的慢性心力衰竭患者中β-肾上腺素能受体多态性与死亡率的关系
机译:美利奴羊的β-肾上腺素能受体(ADRB3)基因座的多态性及其与羔羊死亡率的关系
机译:维生素D受体,金属硫蛋白1A和2A基因多态性对慢性铅暴露工人铅对感觉神经系统的毒性的影响
机译:终末期肾脏疾病患者体内维生素D受体基因多态性与钙化生物标志物的关联。
机译:卡维地洛治疗的慢性心力衰竭患者中β-肾上腺素能受体多态性与死亡率的关系
机译:卡维地洛治疗的慢性心力衰竭患者中β-肾上腺素能受体多态性与死亡率的关系